Navigation Links
Infusion Therapy Raises Death Risk for Some Heart Patients
Date:11/27/2007

Glucose, insulin and potassium mix spells trouble in first three days, study shows

TUESDAY, Nov. 27 (HealthDay News) -- An infusion of glucose, insulin and potassium, a treatment thought to help people right after they have had a heart attack, actually increases the immediate risk of heart failure and death for some patients, a new study shows.

Previous research has produced mixed results, with smaller studies supporting the use of GIK therapy, as the treatment is known, and one larger study showing no effect on the death risk 30 days after a heart attack.

However, patients with an ST-segment elevation myocardial infarction, a type of heart attack commonly known as STEMI that shows a particular electrical pattern, should not be given the infusion right away because that increased risk lingers for them in the first three days after diagnosis, the researchers said in a statement.

"GIK therapy increased levels of glucose, potassium, and net fluid gain post-infusion, all three of which predicted death after adjusting for multiple confounders. Adjusting for glucose, potassium, and net fluid gain eliminated the apparent increase in mortality at 3 days observed with GIK infusion, suggesting a direct association with these factors. Administration of GIK infusion within 4 hours of symptom onset yielded no benefit compared with later initiation," the authors wrote.

Their report is published in the Nov. 28 issue of the Journal of the American Medical Association.

The research team, which included scientists from Argentina and Emory University in Atlanta, analyzed data from two separate trials of almost 23,000 STEMI patients. Although the researchers found no difference in outcome at 30 days and six months, when they looked at the first few days following a heart attack, they discovered an increased risk of both heart failure and death in the patients who received the infusions. In the first three days, there were 1,509 incidents of heart failure or death (15.8 percent) in the infusion group, compared with 1,388 incidents of heart failure or death (14.5 percent) in the control group.

The researchers noted that this largest-ever analysis "demonstrates that GIK infusion has no effect on any important clinical endpoint through 30 days following STEMI. However, contrary to our pre-specified hypothesis, we observed a higher rate of death and the composite of death or heart failure at 3 days in patients allocated to GIK therapy compared with control."

More information

The American Heart Association has more on heart attack treatments.



-- HealthDay News staff



SOURCE: Nov. 28, 2007, Journal of the American Medical Association


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Direct Anesthetic Infusion Helps Colorectal Cancer Patients
2. Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. HIV therapy in pregnancy-data support WHO recommendations
5. Family-based treatment more effective than supportive psychotherapy in treating bulimia
6. Trial to Test Gene Therapy for Angina in Women
7. Novel Cooling Therapy May Have Aided Injured Football Player
8. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
9. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
10. This October, the American Physical Therapy Associations National Physical Therapy Month to Focus on Nations Obesity Epidemic
11. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Infusion Therapy Raises Death Risk for Some Heart Patients
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to ... Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed a ... or restricted lighting. As such, it eliminates the need to turn on a light ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today announced that it will release third-quarter ... October 26, 2017, and will follow with a conference ... 9:00 a.m. Eastern Time. To participate on the call, ... ID is 94093362. ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
Breaking Medicine Technology: